U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H22ClNO5
Molecular Weight 391.845
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-5984

SMILES

C[C@H](CC1=CC=C2O[C@H](COC2=C1)C(O)=O)NC[C@H](O)C3=CC=CC(Cl)=C3

InChI

InChIKey=XSOXUIXLUNBLJA-RNRVQEDPSA-N
InChI=1S/C20H22ClNO5/c1-12(22-10-16(23)14-3-2-4-15(21)9-14)7-13-5-6-17-18(8-13)26-11-19(27-17)20(24)25/h2-6,8-9,12,16,19,22-23H,7,10-11H2,1H3,(H,24,25)/t12-,16+,19-/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H22ClNO5
Molecular Weight 391.845
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 08:23:05 GMT 2023
Edited
by admin
on Sat Dec 16 08:23:05 GMT 2023
Record UNII
TV97A9Z8ZT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-5984
Code English
(R)-6-((R)-2-(((R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)PROPYL)-2,3-DIHYDROBENZO(B)(1,4)DIOXINE-2-CARBOXYLIC ACID
Systematic Name English
KRP-204
Code English
N5984
Code English
1,4-BENZODIOXIN-2-CARBOXYLIC ACID, 6-((2R)-2-(((2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)PROPYL)-2,3-DIHYDRO-, (2R)-
Systematic Name English
(2R)-6-((2R)-2-(((2R)-2-(3-CHLOROPHENYL)-2-HYDROXY-ETHYL)AMINO)PROPYL)-2,3-DIHYDRO-1,4-BENZODIOXINE-2-CARBOXYLIC ACID
Systematic Name English
Code System Code Type Description
PUBCHEM
9865284
Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023
PRIMARY
FDA UNII
TV97A9Z8ZT
Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023
PRIMARY
CAS
220475-76-3
Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
N-5984
Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023
PRIMARY Developer: Kyorin Pharmaceutical Nisshin Pharma; Class: Anti-hyperglycaemic, Carboxylic acid, Dioxin, Obesity therapy, Small molecule; Mechanism of Action: Beta 3 adrenergic receptor agonist;Highest Development Phase: Discontinued for Diabetes mellitus, Obesity, Overactive bladder
Related Record Type Details
ACTIVE MOIETY
Kyorin Pharmaceutical Co. Ltd.'s KRP-204, a selective ADRB3 agonist, is in Phase II testing to treat obesity and incontinence.
ACTIVE MOIETY
Therefore, we examined whether KRP-204, a selective beta3-AR agonist (EC50=1.7 nM, in CHO cells expressing human beta3-AR), acts on C-fiber afferent nerves by observing the licking behavior induced by intravesical instillation of capsaicin in rats.